Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1956 1
1957 1
1960 1
1966 2
1969 1
1975 1
1976 1
1984 1
1985 1
1986 1
1987 1
1988 2
1990 2
1991 1
1993 3
1995 6
1996 2
1997 2
1998 2
1999 1
2000 1
2001 1
2005 2
2007 2
2008 6
2009 2
2010 3
2011 3
2012 2
2013 2
2014 3
2015 4
2016 4
2017 9
2018 10
2019 6
2020 6
2021 6
2022 12
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.
Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, Maciej A, Chuba P, Ahmed AA, Indelicato DJ, Wang D, Marina N, Gorlick R, Janeway KA, Mascarenhas L. Leavey PJ, et al. Among authors: nadel h. J Clin Oncol. 2021 Dec 20;39(36):4029-4038. doi: 10.1200/JCO.21.00358. Epub 2021 Oct 15. J Clin Oncol. 2021. PMID: 34652968 Free PMC article. Clinical Trial.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. Among authors: nadel h. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators. Whelan JS, et al. Among authors: nadel h. Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24. Ann Oncol. 2015. PMID: 25421877 Free PMC article. Clinical Trial.
Bone scan update.
Nadel HR. Nadel HR. Semin Nucl Med. 2007 Sep;37(5):332-9. doi: 10.1053/j.semnuclmed.2007.06.001. Semin Nucl Med. 2007. PMID: 17707240 Review.
ACR Appropriateness Criteria® Ataxia-Child.
Expert Panel on Pediatric Imaging; Radhakrishnan R, Shea LAG, Pruthi S, Silvera VM, Bosemani T, Desai NK, Gilbert DL, Glenn OA, Guimaraes CV, Ho ML, Lam HFS, Maheshwari M, Mirsky DM, Nadel HR, Partap S, Schooler GR, Udayasankar UK, Whitehead MT, Wright JN, Rigsby CK. Expert Panel on Pediatric Imaging, et al. Among authors: nadel hr. J Am Coll Radiol. 2022 Nov;19(11S):S240-S255. doi: 10.1016/j.jacr.2022.09.010. J Am Coll Radiol. 2022. PMID: 36436955
ACR Appropriateness Criteria® Crohn Disease-Child.
Expert Panel on Pediatric Imaging; Moore MM, Gee MS, Iyer RS, Chan SS, Ayers TD, Bardo DME, Chandra T, Cooper ML, Dotson JL, Gadepalli SK, Gill AE, Levin TL, Nadel HR, Schooler GR, Shet NS, Squires JH, Trout AT, Wall JJ, Rigsby CK. Expert Panel on Pediatric Imaging, et al. Among authors: nadel hr. J Am Coll Radiol. 2022 May;19(5S):S19-S36. doi: 10.1016/j.jacr.2022.02.020. J Am Coll Radiol. 2022. PMID: 35550801
SPECT/CT in pediatric patient management.
Nadel HR. Nadel HR. Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S104-14. doi: 10.1007/s00259-014-2697-7. Epub 2014 Feb 20. Eur J Nucl Med Mol Imaging. 2014. PMID: 24554052 Review.
Neonatal renomegaly.
Johnson HW, Gleave M, Coleman GU, Nadel HR, Raffel J, Weckworth PF. Johnson HW, et al. Among authors: nadel hr. J Urol. 1987 Oct;138(4 Pt 2):1023-7. doi: 10.1016/s0022-5347(17)43488-4. J Urol. 1987. PMID: 3309371
Pediatric bone scintigraphy update.
Nadel HR. Nadel HR. Semin Nucl Med. 2010 Jan;40(1):31-40. doi: 10.1053/j.semnuclmed.2009.10.001. Semin Nucl Med. 2010. PMID: 19958848 Review.
109 results